Oxidative-stress-induced epigenetic changes in chronic diabetic complications

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 3, 2013, Pages 213-220

  Feng, Biao ^a   Ruiz, Michael Anthony ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Acetylation; Diabetic complications; Epigenetics; Microrna; Oxidative stress; P300; Sirt1

Indexed keywords

CURCUMIN; E1A ASSOCIATED P300 PROTEIN; ENDOTHELIN 1; FIBRONECTIN; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MICRORNA; RESVERATROL; SIRTUIN 1; VASCULOTROPIN;

ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HISTONE ACETYLATION; HUMAN; HYPERGLYCEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RNA METHYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CHRONIC DISEASE; DIABETES COMPLICATIONS; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84875481512     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0251     Document Type: Review

References (92)

1. Appendino, G., Belcaro, G., Cornelli, U., Luzzi, R., Togni, S., Dugall, M., et al. 2011. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med. 53(3 Suppl. 1): 43-49. PMID:22108476.
2. Arden, G.B., and Sivaprasad, S. 2011. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr. Diabetes Rev. 7(5): 291-304.doi: 10.4093/dmj.2012.36.3.190. PMID:21916837.
3. Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E.K., et al. 2009. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes, 58(5): 1229-1236.doi: 10.2337/db081666. PMID:19208907.
4. Calabrese, V., Cornelius, C., Leso, V., TrovatoSalinaro, A., Ventimiglia, B., Cavallaro, M., et al. 2012. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim. Biophys. Acta, 1822(5): 729-736.doi: 10.1016/j.bbadis.2011.12.003. PMID:22186191.
5. Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13(5): 613-618.doi: 10.1038/nm1582. PMID:17468766.
6. Chen, S., Mukherjee, S., Chakraborty, C., and Chakrabarti, S. 2003a. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am. J. Physiol. Cell Physiol. 284(2): C263-C272.doi: 10. 1152/ajpcell.00192.2002. PMID:12388107.
7. Chen, S., Khan, Z.A., Cukiernik, M., and Chakrabarti, S. 2003b. Differential activation of NF-kappaB and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab. 284(6): E1089-E1097.doi: 10.1152/ajpendo.00540.2002. PMID:12582013.
8. Chen, S., Feng, B., George, B., Chakrabarti, R., Chen, M., and Chakrabarti, S. 2010. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 298(1): E127-E137.doi: 10.1152/ajpendo.00432.2009. PMID:19903865.
9. Chen, W.J., Zhao, G.J., and Tang, C.K. 2012b. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis, 222(2): 314-323.doi: 10.1016/j.atherosclerosis.2012.01.020. PMID:22307089.
10. Chen, H., Wan, Y., Zhou, S., Lu, Y., Zhang, Z., Zhang, R., et al. 2012a. Endotheliumspecific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence. Sci. China Life Sci. 55(6): 467-473.doi: 10.1007/ s11427-012-4329-4. PMID:22744176.
11. Chiu, J., Xu, B.Y., Chen, S., Feng, B., and Chakrabarti, S. 2008. Oxidative stressinduced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Can. J. Physiol. Pharmacol. 86(6): 365-372.doi: 10.1139/Y08-033. PMID:18516100.
12. Chiu, J., Khan, Z.A., Farhangkhoee, H., and Chakrabarti, S. 2009. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition, 25(9): 964-972.doi: 10.1016/j.nut.2008.12.007. PMID:19268536.
13. Cooper, M.E., and El-Osta, A. 2010. Epigenetics: mechanisms and implications for diabetic complications. Circ. Res. 107(10): 1403-1413.doi: 10.1161/ CIRCRESAHA.110.223552. PMID:21148447.
14. Cosgrove, M.S., Boeke, J.D., and Wolberger, C. 2004. Regulated nucleosome mobility and the histone code. Nat. Struct. Mol. Biol. 11(11): 1037-1043.doi: 10.1038/nsmb851. PMID:15523479.
15. Davidson, J.A., Ciulla, T.A., McGill, J.B., Kles, K.A., and Anderson, P.W. 2007. How the diabetic eye loses vision. Endocrine, 32(1): 107-116.doi: 10.1007/s12020-007-0040-9. PMID:17992608.
16. El Mesallamy, H.O., Ahmed, H.H., Bassyouni, A.A., and Ahmed, A.S. 2012. Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clin. Biochem. 45(9): 646-650.doi: 10.1016/j.clinbiochem.2012.02.021. PMID:22421318.
17. Esatbeyoglu, T., Huebbe, P., Ernst, I.M., Chin, D., Wagner, A.E., and Rimbach, G. 2012. Curcumin-from molecule to biological function. Angew. Chem. Int. Ed. Engl. 51(22): 5308-5332.doi: 10.1002/anie.201107724. PMID:22566109
18. Evans, J., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. 2003. Are oxidative stress activated signaling pathways mediators of insulin resistance and beta cell dysfunction? Diabetes, 52(1): 1-8.doi: 10.2337/diabetes.52.1.1. PMID: 1250248.
19. Feng, B., and Chakrabarti, S. 2012. miR-320 regulates glucose induced gene expression in diabetes. ISRN Endocrinol. 2012: 549875.doi: 10.5402/2012/549875. PMID:22900199.
20. Feng, B., Chen, S., Chiu, J., George, B., and Chakrabarti, S. 2008. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am. J. Physiol. Endocrinol. Metab. 294(6): E1119-E1126.doi: 10.1152/ajpendo.00029. 2008. PMID:18413674.
21. Feng, B., Chen, S., George, B., Feng, Q., and Chakrabarti, S. 2010. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab. Res. Rev. 26(1): 40-49.doi: 10.1002/dmrr.1054. PMID:20013939.
22. Feng, B., Chen, S., McArthur, K., Wu, Y., Sen, S., Ding, Q., et al. 2011. miR-146amediated extracellular matrix protein production in chronic diabetes complications. Diabetes, 60(4): 2975-2984.doi: 10.2337/db11-0478. PMID:21885871.
23. Folli, F., Corradi, D., Fanti, P., Davalli, A., Paez, A., Giaccari, A., et al. 2011. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus microand macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr. Diabetes Rev. 7(5): 313-324.doi: 10.2174/ 157339911797415585. PMID:21838680.
24. Friedman, R.C., Farh, K.K., Burge, C.B., and Bartel, D.P. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1): 92-105.doi: 10.1101/gr.082701.108. PMID:18955434.
25. Giugliano, D., Ceriello, A., and Paolisso, G. 1995. Diabetes mellitus, hypertension and cardiovascular diseases: which role for oxidative stress? Metabolism, 44(3): 363-368.doi: 10.1016/0026-0495(95)90167-1. PMID:7885282.
26. Haskins, K., Bradley, B., and Powers, K. 2003. Oxidative stress in type 1 diabetes. Ann. N.Y. Acad. Sci. 1005: 43-54.doi: 10.1196/annals.1288.006. PMID: 14679039.
27. Hassig, C.A., and Schreiber, S.L. 1997. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1(3): 300-308.doi: 10.1016/S1367-5931(97)80066-X. PMID:9667866.
28. Hildmann, C., Riester, D., and Schwienhorst, A. 2007. Histone deacetylases-an important class of cellular regulators with a variety of functions. Appl. Microbiol. Biotechnol. 75(3): 487-497.doi: 10.1007/s00253-007-0911-2. PMID: 17377789.
29. Huang, A., Yang, Y.M., Yan, C., Kaley, G., Hintze, T.H., and Sun, D. 2012. Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice. Diabetes, 1(12): 3181-3188.doi: 10.2337/db12-0559. PMID:22933112.
30. Jain, S., Wei, J., Mitrani, L.R., and Bishopric, N.H. 2012. Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival. Breast Cancer Res. Treat. 135(1): 103-114.doi: 10.1007/s10549-012-2069-6. PMID:22562121.
31. Jordan, S.D., Krüger, M., Willmes, D.M., Redemann, N., Wunderlich, F.T., Brönneke, H.S., et al. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13(4): 434-446.doi: 10.1038/ncb2211. PMID:21441927.
32. Kantharidis, P., Wang, B., Carew, R.M., and Lan, H.Y. 2011. Diabetes complications: the microRNA perspective. Diabetes, 60(7): 1832-1837.doi: 10.2337/db110082. PMID:21709278.
33. Kanwar, Y.S., Wada, J., Sun, L., Xie, P., Wallner, E.I., Chen, S., et al. 2008. Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood), 233(1): 4-11.doi: 10.3181/0705-MR-134. PMID:18156300.
34. Katare, R., Caporali, A., Zentilin, L., Avolio, E., SalaNewby, G., Oikawa, A., et al. 2011. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ. Res. 108(10): 1238-1251.doi: 10.1161/CIRCRESAHA.110. 239111. PMID:21474815.
35. Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J.J., et al. 2007. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-betainduced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U.S.A. 104(9): 3432-3437.doi: 10.1073/pnas.0611192104. PMID: 17360662.
36. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., et al. 2009. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11(7): 881-889.doi: 10.1038/ncb1897. PMID: 19543271.
37. Kato, M., Wang, L., Putta, S., Wang, M., Yuan, H., Sun, G., et al. 2010. Posttranscriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-beta-induced collagen expression in kidney cells. J. Biol. Chem. 285(44): 34004-34015.doi: 10.1074/jbc.M110.165027. PMID:20713358.
38. Kaur, H., Chen, S., Xin, X., Chiu, J., Khan, Z.A., and Chakrabarti, S. 2006. Diabetesinduced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes, 55(11): 3104-3111.doi: 10.2337/db06-0519. PMID: 17065349.
39. Khajehdehi, P., Pakfetrat, M., Javidnia, K., Azad, F., Malekmakan, L., Nasab, M.H., et al. 2011. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand. J. Urol. Nephrol. 45(5): 365-370.doi: 10.3109/00365599.2011. 585622. PMID:21627399.
40. Khan, Z.A., Farhangkhoee, H., Mahon, J.L., Bere, L., Gonder, J.R., Chan, B.M., et al. 2006. Endothelins: regulators of extracellular matrix protein production in diabetes. Exp. Biol. Med. (Maywood), 231(6): 1022-1029. PMID:16741042.
41. Khvorova, A., Reynolds, A., and Jayasena, S.D. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell, 115(2): 209-216.doi: 10.1016/S0092-8674(03) 00801-8. PMID:14567918.
42. Kim, V.N. 2005. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6: 376-385.doi: 10.1038/nrm1644. PMID:15852042.
43. Kovacs, B., Lumayag, S., Cowan, C., and Xu, S. 2011. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci. 52(7): 4402-4409.doi: 10.1167/iovs.10-6879. PMID:21498619.
44. Krupa, A., Jenkins, R., Luo, D.D., Lewis, A., Phillips, A., and Fraser, D. 2010. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21(3): 438-447.doi: 10.1681/ASN.2009050530. PMID:20056746.
45. Kumar, A., and Sharma, S.S. 2010. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun. 394(2): 360-365.doi: 10.1016/j.bbrc.2010.03.014. PMID:20211601.
46. Kumar, A., Negi, G., and Sharma, S.S. 2012. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (I B phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie, 94(5): 1158-1165.doi: 10.1016/j.biochi.2012.01.023. PMID:22342224.
47. Lawler, J.M., and Hindle, A. 2011. Living in a box or call of the wild? Revisiting lifetime inactivity and sarcopenia. Antioxid. Redox Signal. 15(9): 2529-2541.doi: 10.1089/ars.2011.3974. PMID:21539480.
48. Liang, G., Yang, S., Zhou, H., Shao, L., Huang, K., Xiao, J., et al. 2009a. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur. J. Med. Chem. 44(2): 915-919.doi: 10.1016/j.ejmech.2008.01.031. PMID: 18336957.
49. Liang, G., Zhou, H., Wang, Y., Gurley, E.C., Feng, B., Chen, L., et al. 2009b. Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin. J. Cell. Mol. Med. 13(9b): 3370-3379.doi: 10.1111/j.1582-4934.2009.00711.x. PMID:19243473.
50. Lim, L.P., Lau, N.C., GarrettEngele, P., Grimson, A., Schelter, J.M., Castle, J., et al. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433(7027): 769-773.doi: 10.1038/ nature03315. PMID:15685193.
51. Loeffler, I., Liebisch, M., and Wolf, G. 2012. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol. 303(5):F733-F745.doi: 10.1152/ajprenal.00212.2012. PMID: 22759394.
52. Long, J., Wang, Y., Wang, W., Chang, B.H., and Danesh, F.R. 2010. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 285(30): 23457-23465.doi: 10.1074/ jbc.M110.136168. PMID:20501654.
53. Long, J., Wang, Y., Wang, W., Chang, B.H., and Danesh, F.R. 2011. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 286(13): 11837-11848.doi: 10.1074/jbc.M110.194969. PMID:21310958.
54. Majumdar, P., Chen, S., George, B., Sen, S., Karmazyn, M., and Chakrabarti, S. 2009. Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart disease. Diabetes Metab. Res. Rev. 25(5): 452-463.doi: 10.1002/dmrr.964. PMID:19391127.
55. McArthur, K., Feng, B., Wu, Y., Chen, S., and Chakrabarti, S. 2011. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes, 60(4):1314-1323.doi: 10.2337/db10-1557. PMID: 21357793.
56. Miki, T., Yuda, S., Kouzu, H., and Miura, T. 2012. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev. In press.doi: 10.1007/ s10741-012-9313-3. PMID:22453289.
57. Miranda, T.B., and Jones, P.A. 2007. DNA methylation: the nuts and bolts of repression. J. Cell Physiol. 213(2): 384-390.doi: 10.1002/jcp.21224. PMID: 17708532.
58. Mostoslavsky, R., Esteller, M., and Vaquero, A. 2010. At the crossroad of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins. Cell Cycle, 9(10): 1907-1912.doi: 10.4161/cc.9.10.11481. PMID:20458180.
59. Negi, G., Kumar, A., and Sharma, S.S. 2011a. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J. Pineal Res. 50(2): 124-131.doi: 10.1111/j.1600-079X. 2010.00821.x. PMID:21062351.
60. Negi, G., Kumar, A., and Sharma, S.S. 2011b. Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr. Neurovasc. Res. 8(4): 294-304.doi: 10.2174/156720211798120972. PMID:22023613.
61. Niedowicz, D., and abd Daleke, D. 2005. The role of oxidative stress in diabetic complications. Cell Biochem. Biophys. 43(2): 289-330.doi: 10.1385/CBB:43:2: 289. PMID:16049352.
62. Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M.C., Cooper, M.E., et al. 2012. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ. Res. 110(8): 1067-1076.doi: 10.1161/CIRCRESAHA.112.266171. PMID:22403242.
63. Osman, A. 2012. MicroRNAs in health and disease - basic science and clinical applications. Clin. Lab. 58(5-6): 393-402. PMID:22783567.
64. Phillips, M., Cataneo, R.N., Cheema, T., and Greenberg, J. 2004. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin. Chim. Acta, 344(1-2): 189-194.doi: 10.1016/j.cccn.2004.02.025. PMID:15149888.
65. Podwall, D., and Gooch, C. 2004. Diabetic neuropathy: clinical features, etiology, and therapy. Curr. Neurol. Neurosci. Rep. 4(1): 55-61.doi: 10.1007/s11910-004-0013-9. PMID:14683630.
66. Ponugoti, B., Dong, G., and Graves, D.T. 2012. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012: 939751.doi: 10.1155/2012/939751. PMID:22454632.
67. Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M., and Natarajan, R. 2012. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23(3): 458-469.doi: 10.1681/ASN.2011050485. PMID:22223877.
68. Rinn, J.L., and Chang, H.Y. 2012. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81: 145-166.doi: 10.1146/annurev-biochem-051410092902. PMID:22663078.
69. Rosen, P., Nawroth, P.P., King, G., Moller, W., Tritschler, H.J., and Packer, L. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO MCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab. Res. Rev. 17(3): 189-212.doi: 10.1002/dmrr.196. PMID:1142423.
70. Rottiers, V., and Näär, A.M. 2012. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13(4): 239-250.doi: 10.1038/nrm3313. PMID: 22436747.
71. Sharma, S.S., Kumar, A., and Kaundal, R.K. 2008. Protective effects of 4-amino1,8napthalimide, a poly(ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy. Life Sci. 82(11-12): 570-576.doi: 10.1016/j.lfs.2007.11.031. PMID:18262571.
72. Sharma, S.S., Kumar, A., Arora, M., and Kaundal, R.K. 2009. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 napthalimide in experimental diabetic neuropathy: focus on functional sensorimotor and biochemical changes. Free Radic. Res. 43(4): 400-406.doi: 10.1080/ 10715760902801509. PMID:19291593.
73. Silva, V.A., Polesskaya, A., Sousa, T.A., Corrêa, V.M., André, N.D., Reis, R.I., et al. 2011. Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats. Mol. Vis. 17: 2228-2240. PMID: 21897745.
74. Son, S.M. 2012. Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes. Diabetes Metab. J. 36(3): 190-198.doi: 10.4093/dmj.2012.36.3.190. PMID:22737658.
75. Sun, L.L., Jiang, B.G., Li, W.T., Zou, J.J., Shi, Y.Q., and Liu, Z.M. 2011. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res. Clin. Pract. 91(1): 94-100.doi: 10.1016/j.diabres.2010.11. 006. PMID:21146880.
76. Thiagalingam, S., Cheng, K.H., Lee, H.J., Mineva, N., Thiagalingam, A., and Ponte, J.F. 2003. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N.Y. Acad. Sci. 983: 84-100.doi: 10.1111/j.1749-6632. 2003.tb05964.x. PMID:12724214.
77. Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., et al. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature, 474(7353): 649-653.doi: 10.1038/nature10112. PMID:21654750.
78. Valencia-Sanchez, M.A., Liu, J., Hannon, G.J., and Parker, R. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20(5): 515-524.doi: 10.1101/gad.1399806. PMID:16510870.
79. van Rooji, E., Sutherland, L.B., Thatcher, J.E., DiMaio, J.M., Naseem, R.H., Marshall, W.S., et al. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A. 105(35): 13027-13032.doi: 10.1073/pnas.0805038105. PMID:18723672.
80. Wang, Q., Wang, Y., Minto, A.W., Wang, J., Shi, Q., Li, X., et al. 2008. MicroRNA- 377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22(12): 4126-4135.doi: 10.1096/fj.08-112326. PMID: 18716028.
81. Wang, X.H., Qian, R.Z., Zhang, W., Chen, S.F., Jin, H.M., and Hu, R.M. 2009. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 36(2): 181-188.doi: 10.1111/j.1440-1681.2008.05057.x. PMID:18986336.
82. Wang, B., HermanEdelstein, M., Koh, P., Burns, W., JandeleitDahm, K., Watson, A., et al. 2010. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes, 59(7): 1794-1802.doi: 10.2337/db09-1736. PMID: 20393144.
83. Wang, B., Koh, P., Winbanks, C., Coughlan, M.T., McClelland, A., Watson, A., et al. 2011. miR-200a prevents renal fibrogenesis through repression of TGF-b2 expression. Diabetes, 60(1): 280-287.doi: 10.2337/db10-0892. PMID: 20952520.
84. Wang, B., Komers, R., Carew, R., Winbanks, C.E., Xu, B., HermanEdelstein, M., et al. 2012a. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 23(2): 252-265.doi: 10.1681/ASN.2011010055. PMID:22095944.
85. Wang, C., George, B., Chen, S., Feng, B., Li, X., and Chakrabarti, S. 2012b. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. Diabetes Metab. Res. Rev. 28(4): 329-337.doi: 10.1002/dmrr.2279. PMID: 22228707.
86. Williams, M.D., and Mitchell, G.M. 2012. MicroRNAs in insulin resistance and obesity. Exp. Diabetes Res. 2012: 484696.doi: 10.1155/2012/484696. PMID: 22851965.
87. World Health Organization (WHO). 2012. Fact sheet No. 312: Diabetes. Available from http://www.who.int/mediacentre/factsheets/fs312/en/index.html (accessed 28 November 2012).
88. Xu, B., Chiu, J., Feng, B., Chen, S., and Chakrabarti, S. 2008. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Diabetes Metab. Res. Rev. 24(5): 404-412.doi: 10.1002/ dmrr.842. PMID:18351623.
89. Xu, Y., Nie, L., Yin, Y.G., Tang, J.L., Zhou, J.Y., Li, D.D., et al. 2012. Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol. Appl. Pharmacol. 259(3): 395-401.doi: 10.1016/j.taap.2011.09.028. PMID:22015446.
90. Zheng, Z., Chen, H., Li, J., Li, T., Zheng, B., Zheng, Y., et al. 2012. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ ROS pathway and therapeutic effects of metformin. Diabetes, 61(1): 217-228.doi: 10.2337/db11-0416. PMID:22124463.
91. Ziyadeh, F.N. 2008. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res. Clin. Pract. 82(Suppl. 1): S38-S41.doi: 10.1016/j.diabres.2008.09.016. PMID:18842317.
92. Zourek, M., Kyselova, P., Mudra, J., Krcma, M., Jankoveci, Z., Lacigova, S., et al. 2008. The relationship between glycemia, insulin and oxidative stress in hereditary hypertriglyceridemic rats. Physiol. Res. 57(4): 531-538. PMID: 17705681.